Drug Patents owned by Evofem Inc

1. List of Phexxi drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US11439610 EVOFEM INC Compositions and methods for enhancing the efficacy of contraceptive microbicides
Mar, 2033

(10 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6706276 EVOFEM INC Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
Mar, 2023

(a month from now)

US10568855 EVOFEM INC Compositions and methods for enhancing the efficacy of contraceptive microbicides
Mar, 2033

(10 years from now)

US11337989 EVOFEM INC Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound
Mar, 2033

(10 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) May 22, 2023

Drugs and Companies using CITRIC ACID; LACTIC ACID; POTASSIUM BITARTRATE ingredient

Market Authorisation Date: 22 May, 2020

Treatment: Prevention of pregnancy

Dosage: GEL;VAGINAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in